Captrust Financial Advisors Eli Lilly & CO Transaction History

Captrust Financial Advisors

$30.9 Billion
Q2 2024

A detailed history of Captrust Financial Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Captrust Financial Advisors holds 262,268 shares of LLY stock, worth $230 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

262,268

Previous 598,834 56.2%

Holding current value

$230 Million

Previous $466 Million 49.03%

% of portfolio

0.77%

Previous 1.55%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $244 Million - $306 Million	-336,566 Reduced 56.2%	262,268 $237 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $174 Million - $232 Million	293,050 Added 95.84%	598,834 $466 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $1.27 Million - $1.5 Million	-2,426 Reduced 0.79%	305,784 $178 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $2.48 Million - $3.42 Million	5,714 Added 1.89%	308,210 $166 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $23.8 Million - $31.9 Million	-67,925 Reduced 18.34%	302,496 $142 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $62,126 - $72,964	-200 Reduced 0.05%	370,421 $127 Million
Q4 2022 Feb 15, 2023	BUY	$321.55 - $374.67 $7.25 Million - $8.45 Million	22,554 Added 6.48%	370,621 $136 Million
Q3 2022 Nov 16, 2022	SELL	$296.48 - $337.87 $2.29 Million - $2.61 Million	-7,717 Reduced 2.17%	348,067 $113 Million
Q2 2022 Aug 23, 2022	SELL	$278.73 - $327.27 $3.45 Million - $4.05 Million	-12,384 Reduced 3.36%	355,784 $115 Million
Q2 2022 Aug 16, 2022	BUY	$278.73 - $327.27 $15.2 Million - $17.8 Million	54,400 Added 17.34%	368,168 $119 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $7.93 Million - $9.86 Million	33,807 Added 12.08%	313,768 $89.9 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $2.62 Million - $3.25 Million	11,642 Added 4.34%	279,961 $77.3 Million
Q3 2021 Nov 16, 2021	BUY	$221.6 - $272.71 $7.69 Million - $9.47 Million	34,709 Added 14.86%	268,319 $62 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $28.4 Million - $36.7 Million	157,187 Added 205.68%	233,610 $53.6 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $1 Million - $1.3 Million	6,102 Added 8.68%	76,423 $14.3 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $8.58 Million - $11.3 Million	-65,734 Reduced 48.31%	70,321 $11.9 Million
Q3 2020 Nov 17, 2020	BUY	$146.22 - $169.13 $334,990 - $387,476	2,291 Added 1.71%	136,055 $19.6 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $2.71 Million - $3.27 Million	19,897 Added 17.47%	133,764 $21.8 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $3.22 Million - $3.98 Million	27,040 Added 31.14%	113,867 $15.5 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $6.76 Million - $8.37 Million	63,187 Added 267.29%	86,827 $11.5 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $34,706 - $37,752	-325 Reduced 1.36%	23,640 $2.64 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $187,899 - $219,326	-1,696 Reduced 6.61%	23,965 $2.66 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $449,024 - $528,534	4,034 Added 18.65%	25,661 $3.33 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $9,213 - $10,321	87 Added 0.4%	21,627 $2.5 Million
Q3 2018 Nov 15, 2018	BUY	$85.86 - $107.31 $1.06 Million - $1.33 Million	12,360 Added 134.64%	21,540 $2.31 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $513,548 - $589,393	6,784 Added 283.14%	9,180 $783,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $23,376 - $27,594	-315 Reduced 11.62%	2,396 $181,000
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $189,363 - $203,113	2,311 Added 577.75%	2,711 $229,000
Q3 2017 Feb 16, 2018	BUY	$77.07 - $85.54 $30,827 - $34,216	400	400 $30,000

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Eli Lilly & CO Transaction History